Dual 68-Gallium/FDG PET imaging in neuroendocrine tumours

神经内分泌肿瘤的双 68-镓/FDG PET 成像

• 批准号: nhmrc : GNT1150670
• 负责人: Dr David Chan
• 金额: $ 7.4万
• 依托单位国家: 澳大利亚
• 项目类别: Postgraduate Scholarships
• 财政年份: 2018
• 资助国家: 澳大利亚
• 起止时间: 2018-01-01 至 无数据
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/dual-68-galliumfdg-neuroendocrine-tumours/1348943
• 关键词: Dual; 68; Gallium; FDG; PET

Neuroendocrine tumours (NETs) are uncommon cancers. Low-grade tumours may grow very slowly and not require treatment, but high-grade tumours can grow over weeks and have a poor prognosis. Grade is determined by looking at tissue, but this may vary considerably even in different disease sites in the same patient. Two PET scans (FDG PET and 68Gallium PET) can show high grade and low grade disease respectively, and we plan to investigate their combination in imaging advanced neuroendocrine tumours.

神经内分泌肿瘤（NETs）是不常见的癌症。低级别肿瘤可能生长非常缓慢，不需要治疗，但高级别肿瘤可以生长数周，预后不良。分级是通过观察组织来确定的，但即使在同一患者的不同疾病部位，这也可能有很大差异。两种PET扫描（FDG PET和68镓PET）可以分别显示高级别和低级别的疾病，我们计划研究它们在成像晚期神经内分泌肿瘤中的组合。